Integrated Review Refresh

My Lords, first, I simply reiterate that the IDS—the international development strategy—remains our overall strategy, and that does not change. But the changing global context means we need to go further and faster on certain elements of it, not least international development, and we are supercharging that IDS. I cannot answer the question in relation to the spending commitments. I am afraid I am going to have to put that to colleagues in the FCDO, in whose portfolio that sits. But I strongly agree with the noble Lord’s comments about the threat of drug resistance. This is probably the greatest health threat we face today. We take our eye off that very immediate, very grave threat at our peril. I will make sure that his remarks are heard by colleagues in the department. I also believe that on a domestic scale we should be investing in protecting ourselves—insulating ourselves as much as possible against the threat of drug resistance here in the UK as we reach the end of the pipeline of existing antibiotics, partly as a consequence of our abuse of them.